Clinical Trial Update: Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach [Phase 3]

View source ↗

Summary

Phase 3 multi-centre trial (currently recruiting) evaluating whether pharmacologically modulating the noradrenergic arousal system can reduce freezing of gait i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Radboud University Medical Center | Conditions: Parkinson's Disease (PD), Freezing of Gait | Phase 3 | Status: RECRUITING